Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Amedisys Inc (AMED)

Amedisys Inc (AMED)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 8,016,293
  • Shares Outstanding, K 32,572
  • Annual Sales, $ 2,106 M
  • Annual Income, $ 183,610 K
  • 60-Month Beta 0.58
  • Price/Sales 3.86
  • Price/Cash Flow 29.59
  • Price/Book 9.86
Trade AMED with:

Options Overview

Details
  • Implied Volatility 30.20%
  • Historical Volatility 28.22%
  • IV Percentile 7%
  • IV Rank 11.63%
  • IV High 56.36% on 10/28/20
  • IV Low 26.76% on 06/09/21
  • Put/Call Vol Ratio 0.23
  • Today's Volume 38
  • Volume Avg (30-Day) 90
  • Put/Call OI Ratio 2.76
  • Today's Open Interest 2,779
  • Open Int (30-Day) 3,616

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/21
See More
  • Average Estimate 1.63
  • Number of Estimates 7
  • High Estimate 1.72
  • Low Estimate 1.49
  • Prior Year 1.34
  • Growth Rate Est. (year over year) +21.64%

Price Performance

See More
Period Period Low Period High Performance
1-Month
238.47 +2.30%
on 06/18/21
264.00 -7.59%
on 05/26/21
-15.00 (-5.79%)
since 05/21/21
3-Month
238.47 +2.30%
on 06/18/21
292.97 -16.73%
on 04/29/21
-25.24 (-9.38%)
since 03/23/21
52-Week
190.38 +28.14%
on 06/25/20
325.12 -24.96%
on 01/25/21
+45.65 (+23.02%)
since 06/23/20

Most Recent Stories

More News
DVA or AMED: Which Is the Better Value Stock Right Now?

DVA vs. AMED: Which Stock Is the Better Value Option?

DVA : 120.39 (-2.28%)
AMED : 243.96 (-0.87%)
5 Reasons That Make Encompass Health (EHC) an Attractive Bet

Encompass Health's (EHC) optimistic business prospects make it a lucrative stock to own for strong gains.

AMED : 243.96 (-0.87%)
DVA : 120.39 (-2.28%)
LHCG : 199.45 (-0.73%)
EHC : 80.14 (-0.73%)
Encompass Health (EHC) Expands Inpatient Rehab Business

Encompass Health (EHC) continues to strengthen its inpatient rehabilitation business by opening a hospital.

AMED : 243.96 (-0.87%)
DVA : 120.39 (-2.28%)
LHCG : 199.45 (-0.73%)
EHC : 80.14 (-0.73%)
Accuray (ARAY) Expands Commercialization of CE-Marked ClearRT

Accuray's (ARAY) ClearRT imaging capability, which is now widely available following receipt of the CE Mark, offers better precision and accuracy in radiation therapy.

AMED : 243.96 (-0.87%)
ARAY : 4.53 (+2.49%)
AMN : 94.65 (-0.95%)
EYE : 50.54 (+2.56%)
Here's Why You Should Retain LHC Group (LHCG) Stock for Now

Investors continue to be optimistic about LHC Group (LHCG) owing to its slew of buyouts and a broad array of services.

AMED : 243.96 (-0.87%)
LHCG : 199.45 (-0.73%)
AMN : 94.65 (-0.95%)
EYE : 50.54 (+2.56%)
Baxter's (BAX) Theranova-Enabled HDx Therapy Data Positive

Baxter's (BAX) Theranova-enabled HDx therapy is likely to boost clinical outcomes and lower healthcare resource utilization.

AMED : 243.96 (-0.87%)
BAX : 80.93 (-0.49%)
AMN : 94.65 (-0.95%)
EYE : 50.54 (+2.56%)
Why You Should Add Veeva Systems (VEEV) to Your Portfolio

Investors continue to be optimistic about Veeva Systems (VEEV) on its slew of partnerships and robust product adoptions.

AMED : 243.96 (-0.87%)
AMN : 94.65 (-0.95%)
VEEV : 311.12 (-0.35%)
EYE : 50.54 (+2.56%)
Syneos' (SYNH) New Patient Consortium to Drive Innovation

Syneos' (SYNH) Patient Voice Consortium incorporates patient perspective across wide range of communities to guide product development lifecycle.

AMED : 243.96 (-0.87%)
CPSI : 33.24 (+0.48%)
PETQ : 40.23 (-2.09%)
SYNH : 84.99 (-1.04%)
DVA vs. AMED: Which Stock Is the Better Value Option?

DVA vs. AMED: Which Stock Is the Better Value Option?

DVA : 120.39 (-2.28%)
AMED : 243.96 (-0.87%)
Here's Why You Should Retain PRA Health (PRAH) Stock for Now

Investors continue to be optimistic about PRA Health (PRAH) owing to its strategic alliances and solid CRO market prospects.

ILMN : 469.13 (+0.74%)
AMED : 243.96 (-0.87%)
DVA : 120.39 (-2.28%)
PRAH : 166.56 (-0.52%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strongest short term outlook on maintaining the current direction.

See More Share

Business Summary

Amedisys, Inc. is a leading provider of healthcare in the home with a vision of becoming the premiere solution for patients. From home health to hospice to personal care, Amedisys team members provide quality, clinically-distinctive care to patients every year. Amedisys is focused on delivering the care...

See More

Key Turning Points

3rd Resistance Point 253.78
2nd Resistance Point 251.44
1st Resistance Point 247.70
Last Price 243.96
1st Support Level 241.62
2nd Support Level 239.28
3rd Support Level 235.54

See More

52-Week High 325.12
Fibonacci 61.8% 273.65
Fibonacci 50% 257.75
Last Price 243.96
Fibonacci 38.2% 241.85
52-Week Low 190.38

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar